This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
This transformative series will showcase the 2025 Pharma Toolkit for Virtual Medical Education, revealing groundbreaking virtual tools and strategies set to revolutionize how we engage and educate HCPs, patients, and teams. Transform your approach and lead the curve in training!
Our expert speakers will unveil the latest virtual tools that are reshaping how professionals engage with and educate HCPs, patients, and internal teams. Discover innovative methods and technologies designed to elevate training and educational programs to unprecedented levels.
We are excited to host 5 intimate and Pharma-exclusive sessions between November 20–24 where our expert speakers will share real-life examples of highly customizable internal and external learning/training programs. There will also be time for a live Q&A.
Our best-in-class technology and professionalservices ensure that life science organizations around the world can easily and cost-effectively grow and prosperfrom brand or idea discovery to development, commercialization, execution, and beyondin collaboration with colleagues, customers, healthcare providers, payers, and patients.
They will tie in these trends with tips and best practices for how to optimize your insight-gathering programs, conference engagements, patient-centricity efforts, and HCP- or patient-facing materials. Book a Consultative Demo The post KOL Engagement Trends Webinar appeared first on Impetus Digital.
During his medical training at the University of Toronto, he co-led a research project at the University Health Network on hospital readmissions that inspired him to develop technology to help providers engage and monitor patients to prevent adverse outcomes, ultimately leading to him co-founding SeamlessMD in 2012.
Toronto, ON, December 15, 2022 — PM360 , a leading trade magazine for marketing decision-makers in the pharmaceutical, biotech, medical device, and diagnostics industries, has named Impetus Digital’s Virtual Learning Programs as one of the most Innovative Services of 2022.
When I left the Commission and started talking to companies; when I realized that they didn’t have a clue, despite what the Commission believed, then we had to put training in place – I’m not a trainer, never wanted to be a trainer – but yet, we’ve ended up building up the training side.
Keep reading to find out more about how our pharma marketing services can help make 2023 your best year yet. To hit your 2023 goals, you’ll need a trained inside sales team and a multi-channel approach that will cut through the noise of the competition. Extend Your Product Life Cycle & Your Budget.
healthcare system is access to equitable care for our most vulnerable patient populations. Rethinking Healthcare: Addressing Social Determinants in Patient Treatment Practitioners and their staff often dedicate valuable time and resources to understanding the social determinants that may impact their ability to successfully treat a patient.
These new codes were finalized to reflect the value of practitioners’ efforts to reduce/remove health-related social barriers for patients with serious illnesses. Prior to this rule, reimbursement for these activities was assumed in payment for other services, such as evaluation and management (E/M) visits and care management.
These new codes were finalized to reflect the value of practitioners’ efforts to reduce/remove health-related social barriers for patients with serious illnesses. Prior to this rule, reimbursement for these activities was assumed in payment for other services, such as evaluation and management (E/M) visits and care management.
Note: For those patients with a diagnosed substance use disorder (SUD), CMS already reimburses for telehealth services provided in the patient’s home for treatment of that disorder or a co-occurring mental health disorder.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content